Insider Transactions Reported by 53 Insiders of Keenova Therapeutics plc

Location
Dublin 15

Insiders trading volume in the past year

Keenova Therapeutics plc executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
GOLDENTREE ASSET MANAGEMENT LP 10%+ Owner $736,139,041 +$7,562,250 +1% 04 Aug 2025
Silver Point Capital L.P. 10%+ Owner $456,887,866 +$67,917,443 +17% 07 Jan 2026
Alta Fundamental Advisers LLC 10%+ Owner $73,015,988 16 Jun 2023
Olafsson Sigurdur O President and CEO, Director $2,814,973 25 Feb 2026
Christiana Stamoulis President and CFO $1,582,235 25 Feb 2026
David J. Stetson Director $1,001,497 31 Jul 2025
Wesley Wheeler Director $869,585 31 Jul 2025
Abbas Hussain Director $846,230 31 Jul 2025
Paul Efron Director $781,319 23 Feb 2026
Lisa French EVP & Chief Commercial Officer $744,613 25 Feb 2026
Mark Anthony Tyndall EVP & CLO and Corp Sec $724,821 25 Feb 2026
Jon Zinman Director $712,751 23 Feb 2026
Henriette Nielsen EVP & Chief Transformation OFC $668,998 25 Feb 2026
Bradley Mark T. EVP, Chief Integration Officer $371,431 31 Jul 2025
Paul Bisaro Director $370,798 23 Feb 2026
Katina Dorton Director $222,319 23 Feb 2026
Hugh Paul ONeill EVP, Chief Operations Officer $159,928 25 Feb 2026
Sophia D. Langlois Director $68,768 23 Feb 2026
Marc J. Yoskowitz Director $68,076 23 Feb 2026
Tracy Basso Evp & Chro $67,643 25 Feb 2026
Susan Ann Williamson EVP & Chief Compliance Officer $62,799 25 Feb 2026
Cheryl Ann Stouch EVP & Chief Info Officer $54,582 25 Feb 2026
Scott Hirsch Director $39,358 23 Feb 2026
Marek Honczarenko EVP, Chief Scientific Officer 25 Feb 2026
Leslie E. Donato Director 23 Feb 2026
David R. Carlucci Director 16 Jun 2022
Frank B. Raciti Controller & CAO 19 Aug 2025
Kassie Harrold EVP & Chief Compliance Officer 01 Jan 2025
David Y. Norton Director 16 Jun 2022
James R. Sulat Director 14 Nov 2023
Steven J. Romano EVP & Chief Sci. Ofcr 16 Jun 2022
Paul Rutherford Carter Director 16 Jun 2022
Daniel Arthur Celentano Director 14 Nov 2023
Riad El-Dada Director 14 Nov 2023
J. Martin Carroll Director 16 Jun 2022
Peter C. Richardson EVP & Chief Scientific Officer 31 Jul 2025
Karen Ling Director 14 Nov 2023
Ian J. Watkins EVP & Chief Human Resources Officer 16 Jun 2022
Woodrow A. Myers Jr. Director 14 Nov 2023
Mark Trudeau President and CEO, Director 16 Jun 2022
Joann A. Reed Director 16 Jun 2022
Mark J. Casey EVP & Chief Legal Officer 16 Jun 2022
Bryan M. Reasons Evp & Cfo 31 Jul 2025
Jason Daniel Goodson EVP & Chief Strategy Officer 01 Jan 2025
Hugh M. O'Neill EVP & Chief Comm and Ops Ofcr 16 Jun 2022
Stephen Andrew Welch EVP & Head of Spec Generics 10 Nov 2025
Angus C. Russell Director 16 Jun 2022
Bracebridge Capital, LLC 10%+ Owner 14 Nov 2023
Neal P. Goldman Director 14 Nov 2023
Susan Michele Silbermann Director 14 Nov 2023
Anne Clem Whitaker Director 16 Jun 2022
Dr. Kneeland Youngblood Director 16 Jun 2022
Carlos Paya V Director 16 Jun 2022

Recent Insider Transactions by Companies or Individuals for Keenova Therapeutics plc

Showing up to 300 most recent insider transactions from the last 12 months.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
Henriette Nielsen Restricted Stock Units Award 112.5% 51,794 97,825 25 Feb 2026 Direct
Marek Honczarenko Restricted Stock Units Award 58,434 58,434 25 Feb 2026 Direct
Lisa French Restricted Stock Units Award 112.5% 51,794 97,825 25 Feb 2026 Direct
Tracy Basso Restricted Stock Units Award 251.8% 34,528 48,240 25 Feb 2026 Direct
Susan Ann Williamson Restricted Stock Units Award 135.7% 15,936 27,683 25 Feb 2026 Direct
Mark Anthony Tyndall Restricted Stock Units Award 112.5% 51,794 97,825 25 Feb 2026 Direct
Cheryl Ann Stouch Restricted Stock Units Award 155.7% 15,936 26,169 25 Feb 2026 Direct
Christiana Stamoulis Restricted Stock Units Award 138.9% 101,262 174,181 25 Feb 2026 Direct
Hugh Paul ONeill Restricted Stock Units Award 240% 34,528 48,913 25 Feb 2026 Direct
Olafsson Sigurdur O Restricted Stock Units Award 64.4% 198,539 506,815 25 Feb 2026 Direct
Jon Zinman Restricted Stock Units Award 11.2% 3,984 39,554 23 Feb 2026 Direct
Marc J. Yoskowitz Restricted Stock Units Award 81.6% 5,312 11,821 23 Feb 2026 Direct
Sophia D. Langlois Restricted Stock Units Award 81.6% 3,984 8,866 23 Feb 2026 Direct
Scott Hirsch Restricted Stock Units Award 81.6% 3,984 8,866 23 Feb 2026 Direct
Paul Efron Restricted Stock Units Award 61.2% 3,984 10,494 23 Feb 2026 Direct
Katina Dorton Restricted Stock Units Award 14.3% 3,984 31,882 23 Feb 2026 Direct
Leslie E. Donato Restricted Stock Units Award 81.6% 3,984 8,866 23 Feb 2026 Direct
Paul Bisaro Restricted Stock Units Award 9.21% 3,984 47,225 23 Feb 2026 Direct
Silver Point Capital L.P. Common Stock Purchase 5.32% $23,062,500 $92.25 250,000 4,952,714 07 Jan 2026 Direct
Jon Zinman Ordinary Shares Options Exercise 120.2% 4,384 8,031 01 Jan 2026 By JZ Advisors LLC
Jon Zinman Restricted Stock Units Options Exercise -11% -4,384 35,570 01 Jan 2026 Direct
Mark Anthony Tyndall Ordinary Shares Tax liability -20.5% -2,107 8,167 01 Jan 2026 Direct
Mark Anthony Tyndall Ordinary Shares Options Exercise 177.8% 6,576 10,274 01 Jan 2026 Direct
Mark Anthony Tyndall Restricted Stock Units Options Exercise -12.5% -6,576 46,031 01 Jan 2026 Direct
Hugh Paul ONeill Ordinary Shares Tax liability -37.3% -1,073 1,802 01 Jan 2026 Direct
Hugh Paul ONeill Ordinary Shares Options Exercise 250.6% 2,055 2,875 01 Jan 2026 Direct
Hugh Paul ONeill Restricted Stock Units Options Exercise -12.5% -2,055 14,385 01 Jan 2026 Direct
Olafsson Sigurdur O Ordinary Shares Tax liability -34.8% -16,939 31,718 01 Jan 2026 Direct
Olafsson Sigurdur O Ordinary Shares Options Exercise 208.4% 32,878 48,657 01 Jan 2026 Direct
Olafsson Sigurdur O Restricted Stock Units Options Exercise -9.64% -32,878 308,276 01 Jan 2026 Direct
Henriette Nielsen Ordinary Shares Tax liability -24.1% -2,398 7,538 01 Jan 2026 Direct
Henriette Nielsen Ordinary Shares Options Exercise 195.7% 6,576 9,936 01 Jan 2026 Direct
Henriette Nielsen Restricted Stock Units Options Exercise -12.5% -6,576 46,031 01 Jan 2026 Direct
Lisa French Ordinary Shares Tax liability -19.1% -1,986 8,390 01 Jan 2026 Direct
Lisa French Ordinary Shares Options Exercise 173% 6,576 10,376 01 Jan 2026 Direct
Lisa French Restricted Stock Units Options Exercise -12.5% -6,576 46,031 01 Jan 2026 Direct
Katina Dorton Ordinary Shares Tax liability -17% -513 2,505 01 Jan 2026 Direct
Katina Dorton Ordinary Shares Options Exercise 149.4% 1,808 3,018 01 Jan 2026 Direct
Katina Dorton Restricted Stock Units Options Exercise -6.09% -1,808 27,898 01 Jan 2026 Direct
Katina Dorton Restricted Stock Units Disposed to Issuer -4.75% -1,480 29,706 01 Jan 2026 Direct
Paul Bisaro Ordinary Shares Tax liability -17% -854 4,178 01 Jan 2026 Direct
Paul Bisaro Ordinary Shares Options Exercise 149.4% 3,014 5,032 01 Jan 2026 Direct
Paul Bisaro Restricted Stock Units Options Exercise -6.52% -3,014 43,241 01 Jan 2026 Direct
Paul Bisaro Restricted Stock Units Disposed to Issuer -5.06% -2,466 46,255 01 Jan 2026 Direct
Christiana Stamoulis Ordinary Shares Tax liability -51.1% -18,631 17,828 19 Dec 2025 Direct
Christiana Stamoulis Ordinary Shares Options Exercise 30,335 30,335 15 Dec 2025 Direct
Christiana Stamoulis Restricted Stock Units Options Exercise -33.3% -30,335 60,672 15 Dec 2025 Direct
Silver Point Capital L.P. Common Stock Purchase 2.86% $11,623,942 $88.75 130,974 4,702,714 08 Dec 2025 Direct
Silver Point Capital L.P. Common Stock Purchase 0.93% $3,732,750 $88.88 42,000 4,571,740 19 Nov 2025 Direct
Silver Point Capital L.P. Common Stock Purchase 0.58% $2,310,750 $88.88 26,000 4,529,740 17 Nov 2025 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.